AI is Already Changing Drug Discovery—What’s Next? Breakthroughs in AI-driven drug discovery are happening now. AI is scanning millions of genetic mutations, designing new drug candidates, and accelerating clinical trials at a pace never seen before. 💡 What does this mean for biotech, pharma, and healthcare? -AI-designed drugs are entering human trials faster than ever. -Precision medicine is evolving—targeting diseases once thought “undruggable.” -Investors are betting big on AI-driven drug development, reshaping R&D strategies. The industry is at a tipping point. Will Gen AI redefine drug discovery—or are we still in the hype phase? Join VLAB on Thursday, March 20 in San Francisco as pharma executives, ML scientists, AI engineers, industry experts, VCs, and AI pioneers break down the real impact of AI on drug development, clinical trials, and the future of medicine. 🎟️ Limited seating. Secure your spot today: https://www.eventbrite.com/e/the-future-of-drug-discovery-is-generative-ai-the-next-breakthrough-tickets-1237850838179 #GenerativeAI #DrugDiscovery #Biotech #AIinHealthcare #VLAB #AIDrugDiscovery (fb)

(fb)